(AMED) Amundi Index Solutions - Ratings and Ratios
European Stocks, Equity Funds, Large Cap Stocks
Description: AMED Amundi Index Solutions
Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (XETRA:AMED) is an ETF that tracks the Morningstar Developed Europe Zone TME NR EUR Index, focusing on Eurozone large-cap equities with a strong ESG (Environmental, Social, and Governance) profile.
The fund has a significant AUM of €1.217 billion, indicating a substantial investor base and liquidity. As an ESG-focused ETF, it is likely to appeal to investors prioritizing sustainability and responsible investing. The underlying index methodology likely incorporates ESG criteria to select constituents, potentially leading to a portfolio with a better ESG profile compared to a non-ESG filtered index.
From a trading perspective, AMED has shown a relatively stable price action, with a 52-week high of €328.60 and a low of €276.00. The current price is €320.15, near its SMA20 and SMA50, indicating a potential support level. The ATR of 0.82% suggests moderate volatility, which may be attractive to traders seeking to balance risk and potential returns.
To further evaluate AMED, key performance indicators (KPIs) such as tracking error, information ratio, and ESG metrics (e.g., carbon footprint, ESG score) could be analyzed. Additionally, comparing AMEDs performance and fees to similar ESG-focused Eurozone large-cap ETFs could provide insights into its relative attractiveness.
Investors should also consider the funds sector allocation, top holdings, and the overall ESG strategy to ensure alignment with their investment objectives and values. A thorough analysis of these factors will help determine whether AMED is a suitable addition to their portfolio.
Additional Sources for AMED ETF
AMED ETF Overview
Market Cap in USD | 1,423m |
Category | Eurozone Large-Cap Equity |
TER | 0.25% |
IPO / Inception | 2018-02-14 |
AMED ETF Ratings
Growth Rating | 68.3 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -4.4 |
Analysts | - |
Fair Price Momentum | 307.05 EUR |
Fair Price DCF | - |
AMED Dividends
Currently no dividends paidAMED Growth Ratios
Growth Correlation 3m | 48.8% |
Growth Correlation 12m | 72.4% |
Growth Correlation 5y | 86.8% |
CAGR 5y | 9.94% |
CAGR/Max DD 5y | 0.41 |
Sharpe Ratio 12m | 1.29 |
Alpha | -0.29 |
Beta | 0.535 |
Volatility | 11.01% |
Current Volume | 0.1k |
Average Volume 20d | 0.2k |
Stop Loss | 313.5 (-3.5%) |
As of July 14, 2025, the stock is trading at EUR 324.85 with a total of 69 shares traded.
Over the past week, the price has changed by +0.59%, over one month by +1.55%, over three months by +11.00% and over the past year by +8.19%.
Yes. Based on ValueRay's Analyses, Amundi Index Solutions (XETRA:AMED) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.30 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMED is around 307.05 EUR . This means that AMED is currently overvalued and has a potential downside of -5.48%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, AMED Amundi Index Solutions will be worth about 346 in July 2026. The stock is currently trading at 324.85. This means that the stock has a potential upside of +6.5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 346 | 6.5% |